Mb Pharma Limited in Dunfermline, KY12 7NZ

Description

Data updated on: 01-11-2023

Started with Reg No. SC551147 eight years ago, Mb Pharma Limited was set up as a Private Limited Company. The business present office address is 10 Abbey Park Place, Dunfermline. This business's SIC code is 46460 and has the NACE code: Wholesale of pharmaceutical goods. Wednesday 30th November 2022 is the last time the accounts were filed.

Currently, the following company is the workplace of 1 director: Mark B., who was designated to this position eight years ago.

Mark B. is the individual with significant control over this firm, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2017-11-30	2018-11-30	2019-11-30	2020-11-30	2021-11-30	2022-11-30
Currency

Balance Sheet
Cash Bank On Hand	1	1	52 304	118 732	50 125	86 250
Current Assets		1	209 077	221 310	201 900	385 482
Debtors			107 091	51 889	54 392	213 229
Net Assets Liabilities	1	1	7 136	382	-38 462	82 981
Other Debtors			10 012		7 288	113 285
Property Plant Equipment			76 178	120 815	563 430	536 944
Total Inventories			49 682	50 689	97 383

Other Financial Data
Accrued Liabilities Deferred Income			47 549	54 199	144 550	136 893
Accrued Liabilities Not Expressed Within Creditors Subtotal				3 150
Accumulated Amortisation Impairment Intangible Assets			70 333	175 833	281 333	424 833
Accumulated Depreciation Impairment Property Plant Equipment			10 940	29 940	55 916	90 993
Additions Other Than Through Business Combinations Property Plant Equipment			87 118	63 637	468 591	8 591
Average Number Employees During Period			9	8	6	11
Bank Borrowings Overdrafts			720 280	676 306	1 243 760	1 181 200
Corporation Tax Payable				11 901	1 423	67 077
Creditors			730 803	678 999	1 243 760	1 181 200
Dividends Paid On Shares			984 667
Finance Lease Liabilities Present Value Total			10 523	2 693	2 693
Fixed Assets			1 060 845	999 982	1 717 097	1 547 111
Future Minimum Lease Payments Under Non-cancellable Operating Leases			182 500	175 000	167 500	160 000
Increase From Amortisation Charge For Year Intangible Assets			70 333	105 500	105 500	143 500
Increase From Depreciation Charge For Year Property Plant Equipment			10 940	19 000	25 976	35 077
Intangible Assets			984 667	879 167	1 153 667	1 010 167
Intangible Assets Gross Cost			1 055 000	1 055 000	1 435 000
Net Current Assets Liabilities		1	-314 359	-297 356	-479 132	-256 545
Other Creditors			426 816	400 499	433 915	340 459
Other Taxation Social Security Payable			232	1 410	1 769	1 873
Property Plant Equipment Gross Cost			87 118	150 755	619 346	627 937
Provisions For Liabilities Balance Sheet Subtotal			8 547	23 245	32 667	26 385
Taxation Including Deferred Taxation Balance Sheet Subtotal			8 547	23 245	32 667	26 385
Total Assets Less Current Liabilities		1	746 486	702 626	1 237 965	1 290 566
Trade Debtors Trade Receivables			97 079	51 889	47 104	99 944
Number Shares Allotted	1	1
Par Value Share	1	1

Company staff

Mark B.

Role: Director

Appointed: 25 November 2016

Latest update: 6 February 2024

People with significant control

Mark B.

Notified on 25 November 2016

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

Accounts Documents

Account next due date	31 August 2024
Account last made up date	30 November 2022
Confirmation statement next due date	08 December 2023
Confirmation statement last made up date	24 November 2022

Annual Accounts
Start Date For Period Covered By Report	2016-11-25
End Date For Period Covered By Report	2017-11-30
Annual Accounts
Start Date For Period Covered By Report	2017-12-01
End Date For Period Covered By Report	2018-11-30
Annual Accounts
Start Date For Period Covered By Report	2018-12-01
End Date For Period Covered By Report	2019-11-30
Annual Accounts
Start Date For Period Covered By Report	2019-12-01
End Date For Period Covered By Report	2020-11-30
Annual Accounts
Start Date For Period Covered By Report	2020-12-01
End Date For Period Covered By Report	2021-11-30
Annual Accounts
Start Date For Period Covered By Report	2021-12-01
End Date For Period Covered By Report	2022-11-30

Mb Pharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Mark B.

People with significant control

Mark B.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest companies